Literature DB >> 24027253

An important complication of a child with juvenile idiopathic arthritis: macrophage activation syndrome.

Yuvaram N V Reddy1, Navin Bhatia, Julius Xavier Scott, Priyathersini Nagarajan.   

Abstract

A 4-year-old girl, a known case of juvenile idiopathic arthritis for 2 years presented to us with high-grade fever and abdominal distension for 2 months. On examination, her temperature was 104 ° F and she was found to be pale with bilateral cervical lymphadenopathy of up to 3 × 3 cm in size. Her liver was enlarged with a firm consistency and a span of 12 cm. Her spleen was enlarged up to 3 cm along its long axis. The rest of her systemic examination was normal. Laboratory investigations revealed leucocytosis, anaemia and thrombocytopenia with a mildly elevated erythrocyte sedimentation rate. Serum ferritin was 16 500 ng/dL and lactate dehydrogenase was 2311 U/L. A bone marrow aspirate showed macrophages showing ingested nuclei. She was diagnosed as having macrophage activation syndrome and was initiated on intravenous methylprednisolone 300 mg daily for 3 days and was switched over to oral prednisolone 2 mg/kg/day. She is currently doing well on follow-up.

Entities:  

Mesh:

Year:  2013        PMID: 24027253      PMCID: PMC3794201          DOI: 10.1136/bcr-2013-200397

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  The incidence of macrophage activation syndrome in children with rheumatic disorders.

Authors:  M H Moradinejad; V Ziaee
Journal:  Minerva Pediatr       Date:  2011-12       Impact factor: 1.312

2.  Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Authors:  A Ravelli; M C Caria; S Buratti; C Malattia; F Temporini; A Martini
Journal:  J Rheumatol       Date:  2001-04       Impact factor: 4.666

3.  Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders.

Authors:  S Sawhney; P Woo; K J Murray
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

4.  Macrophage activation syndrome in systemic juvenile rheumatoid arthritis.

Authors:  A A Grom; M Passo
Journal:  J Pediatr       Date:  1996-11       Impact factor: 4.406

Review 5.  Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.

Authors:  B E Favara; A C Feller; M Pauli; E S Jaffe; L M Weiss; M Arico; P Bucsky; R M Egeler; G Elinder; H Gadner; M Gresik; J I Henter; S Imashuku; G Janka-Schaub; R Jaffe; S Ladisch; C Nezelof; J Pritchard
Journal:  Med Pediatr Oncol       Date:  1997-09

6.  Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production.

Authors:  M G Attur; R Patel; G Thakker; P Vyas; D Levartovsky; P Patel; S Naqvi; R Raza; K Patel; D Abramson; G Bruno; S B Abramson; A R Amin
Journal:  Inflamm Res       Date:  2000-01       Impact factor: 4.575

7.  Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.

Authors:  Marieke H Otten; Femke H M Prince; Wineke Armbrust; Rebecca ten Cate; Esther P A H Hoppenreijs; Marinka Twilt; Yvonne Koopman-Keemink; Simone L Gorter; Koert M Dolman; Joost F Swart; J Merlijn van den Berg; Nico M Wulffraat; Marion A J van Rossum; Lisette W A van Suijlekom-Smit
Journal:  JAMA       Date:  2011-11-06       Impact factor: 56.272

8.  Hypercytokinemia in familial hemophagocytic lymphohistiocytosis.

Authors:  J I Henter; G Elinder; O Söder; M Hansson; B Andersson; U Andersson
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

Review 9.  Macrophage activation syndrome.

Authors:  Angelo Ravelli
Journal:  Curr Opin Rheumatol       Date:  2002-09       Impact factor: 5.006

10.  Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level.

Authors:  J E García; A M López; M R de Cabo; F M Rodríguez; J P Losada; R G Sarmiento; A J López; J L Arellano
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.